ALEXEI ARKHIPOV
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology SAN ANTONIO, TX NPI 1700980299
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology TX Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$15,378.00
- Category: General Payments
- Program years: PY2018–2024
- Record count: 651
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,990.48 across 84 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,964.76 | 83 |
| Education | $25.72 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $336.39 | 14 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $222.10 | 9 |
| PFIZER INC. | $158.80 | 8 |
| GENZYME CORPORATION | $157.89 | 6 |
| Incyte Corporation | $149.57 | 6 |
| Acerta Pharma LLC | $134.98 | 6 |
| GlaxoSmithKline, LLC. | $114.28 | 6 |
| Janssen Pharmaceuticals, Inc | $111.36 | 4 |
| Merck Sharp & Dohme Corporation | $106.67 | 5 |
| Daiichi Sankyo Inc. | $102.42 | 4 |
| EISAI INC. | $83.76 | 4 |
| Celgene Corporation | $59.97 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $58.02 | 2 |
| AVEO Pharmaceuticals, Inc. | $52.40 | 2 |
| E.R. Squibb & Sons, L.L.C. | $37.98 | 2 |
| ADC Therapeutics America, Inc. | $35.30 | 1 |
| SOBI, INC | $27.09 | 1 |
| SHIELD THERAPEUTICS INC | $21.70 | 1 |
| ARRAY BIOPHARMA INC | $19.80 | 1 |
By program year
Records — PY2024 (84)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.